Accelerating Pediatric Rare-Disease Drug Development: Trial Design, Recruitment, and Regulatory strategy for Early-Life Impact

  • Designing development strategies that support earlier intervention and improve long-term outcomes
  • Gaining practical insights into how to optimize trial design, patient recruitment, and the use of real-world endpoints
  • Addressing the complexities of small, heterogeneous pediatric populations to enhance study feasibility and success
  • Engaging regulators effectively and plan for how pediatric medicines are evaluated differently—especially for cell and gene therapies and earlier treatment approaches